Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Torsion of the Vermiform Appendix in an 18-Day-Old Neonate: A Case Report from Romania and Review of the Literature.

Reports (MDPI)·2026
Same author

Angiogenic Imbalance Defines Multisystem Phenotypes of Preeclampsia: A Phenotype-Oriented Cohort Study.

Clinics and practice·2026
Same author

sFlt-1/PlGF Ratio as a Central Biomarker for Preeclampsia and Perinatal Outcomes: A Multisystem Retrospective Cohort Study.

Journal of clinical medicine·2026
Same author

Clinical Relevance of Trace-Positive Results in Xpert MTB/RIF Ultra for Tuberculosis Diagnosis in a High-Burden Setting: A Retrospective Cohort Study.

Diagnostics (Basel, Switzerland)·2025
Same author

Analysis of Pharmacological Properties of <i>Nigella sativa</i> L. Bioactive Compounds and Their Therapeutic Relevance in the Management of Type 2 Diabetes Mellitus.

Life (Basel, Switzerland)·2025
Same author

Antibiotic Use in Pediatrics: Perceptions and Practices of Romanian Physicians.

Antibiotics (Basel, Switzerland)·2025

Related Experiment Video

Updated: May 11, 2026

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

18.2K

Thrombosis in Children: A Retrospective Study from a Single-center Database.

Cristian Sava1,2, Alin Iuhas3,2, Andreea Balmoș1,2

  • 1Faculty of Medicine and Pharmacy, University of Oradea, Oradea, Romania.

In Vivo (Athens, Greece)
|December 31, 2024
PubMed
Summary

Pediatric thrombotic events are increasingly recognized, with venous thromboembolism being most common. Improved awareness and diagnostic approaches are crucial for accurate diagnosis and treatment of pediatric thrombosis.

Keywords:
Thrombosis in childrendiagnosis of thrombosispulmonary thromboembolismstrokethrombophiliatreatment of thrombosisvenous thromboembolism

More Related Videos

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.1K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

14.8K

Related Experiment Videos

Last Updated: May 11, 2026

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

18.2K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.1K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

14.8K

Area of Science:

  • Pediatric Hematology
  • Thrombosis Research
  • Epidemiology

Background:

  • Pediatric thrombotic events are increasingly identified due to advanced diagnostics.
  • These events are less common than in adults and often linked to risk factors.
  • Challenges in diagnosis exist, especially in smaller medical centers.

Purpose of the Study:

  • To establish epidemiological data on pediatric thrombotic events in Bihor County, Romania.
  • To highlight diagnostic challenges in pediatric thrombosis.
  • To propose a diagnostic and treatment algorithm for pediatric thrombotic events.

Main Methods:

  • Retrospective study over 22 years.
  • Involved 39 pediatric patients diagnosed with thrombotic events.
  • Data collected from electronic medical records at a regional hospital.

Main Results:

  • Most diagnoses (82.1%) occurred between 2013-2024.
  • Two age peaks: newborns and adolescents.
  • Venous thromboembolism (53.8%) was most common, followed by arterial (41%).
  • Cerebral thrombosis was most frequent, followed by limb events.
  • Inherited thrombophilia (antithrombin, protein S, C deficiencies) and acquired factors (malignancy) were identified.
  • PAI-1 4G/5G was the most common genetic variant.

Conclusions:

  • Recognition of pediatric thromboembolism has risen significantly over two decades.
  • Underdiagnosis remains a concern.
  • Enhanced healthcare professional awareness is vital for unprovoked thrombosis cases.
  • Multidisciplinary team involvement and thrombophilia panel testing are recommended.